Hypercalcemia due to constitutive activity of the parathyroid hormone (PTH)/PTH-related peptide receptor: Comparison with primary hyperparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 10, 1996, Pages 3584-3588

  Parfitt, A M ^a,c   Schipani, E ^b   Rao, D Sudhaker ^a   Kupin, W ^a   Han, Z H ^a   Juppner H ^b  

^a HENRY FORD HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCIUM; CYCLIC AMP; GLUCOCORTICOID; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHATE;

ADULT; AGED; ALBRIGHT SYNDROME; ARTICLE; BONE DYSPLASIA; BONE METABOLISM; BONE TURNOVER; CALCIUM METABOLISM; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERCALCEMIA; KIDNEY TUBULE ABSORPTION; PARATHYROID HORMONE RELEASE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RECEPTOR OCCUPANCY;

BONE DISEASES, DEVELOPMENTAL; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; MUTATION; RECEPTOR, PARATHYROID HORMONE, TYPE 1; RECEPTORS, PARATHYROID HORMONE;

EID: 0029846161     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.10.3584     Document Type: Article

References (41)

1. Jansen M. 1934 Über atypische chondrodystrophie (Achondroplasie) und über eine noch nicht beschriebene angeborene Wachstrumsstörung des knochen-systems: Metaphysäre dysostosis. Zeitschr Orthop Chir. 61:253-286.
2. Holthusen W, Holt JF, Stoeckenius M. 1975 The skull in metaphyseal chondrodysplasia type Jansen. Pediatr Radiol. 3:137-144.
3. Charrow J, Poznanski AK. 1984 The Jansen type of metaphyseal chondrodysplasia: conformation of dominant inheritance and review of radiographic manifestations in the newborn and adult. J Med Genet. 18:321-327.
4. Gram PB, Fleming JL, Frame B, Fine G. 1959 Metaphyseal chondrodysplasia of Jansen. J Bone Joint Surg 41A:951-959.
5. Kruse K, Schütz C. 1993 Calcium metabolism in the Jansen type of metaphyseal dysplasia. Eur J Pediatr. 152:912-915.
6. Rao DS, Frame B, Reynolds WA, Parfitt AM. 1979 Hypercalcemia in metaphyseal chondrodysplasia of Jansen (MCD): an enigma. In: Norman AW, Schaefer K, von Herrath D, Grigoleit HG, Coburn JW, DeLuca HF, Mawer EB, Suda T, eds. Vitamin D, basic research and its clinical application. Berlin: de Gruyter; 1173-1176.
7. Frame B, Poznanski AK. 1980 Conditions that may be confused with rickets. In: DeLuca F, Anast CS, eds. Pediatric diseases related to calcium. New York: Elsevier; 269-289.
8. Grill V, Martin TJ. 1994 Parathyroid hormone related protein as a cause of hypercalcemia in malignancy. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids-basic and clinical concepts. New York: Raven Press; 295-310.
9. Karaplis AC, Luz A, Glowacki J, et al. 1994 Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 8:277-289.
10. Lanske B, Karaplis AC, Luz A, Mulligan RC, Kronenberg HM. 1994 Characterization of mice homozygous for the PTH/PTHrP receptor gene null mutation. J Bone Miner Res. 9(Suppl 1):S121.
11. Schipani E, Kruse K, Jüppner H. 1995 A 1constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science. 268:98-100.
12. Schipani E, Langman CB, Parfitt AM, et al. Two different constitutively active PTH/PTHrP receptor mutations cause Jansen-type metaphyseal chondrodysplasia. N Engl J Med. In press.
13. Peacock M, Robertson WG, Nordin BEC. 1969 Relation between serum and urinary calcium with particular reference to parathyroid activity. Lancet. 1:384-386.
14. Jones KL, Smith DW. 1975 The Williams elfin facies syndrome: a new perspective. J Pediatr. 86:718-723.
15. Benson RC, Riggs BL, Pickard BM, Arnaud CD. 1974 Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease. Am J Med. 56:821-826.
16. Kleerekoper M, Ingham JP, McCarthy SW, Posen S. 1974 Parathyroid hormone assay in primary hyperparathyroidism: experiences with a radioimmunoassay based on commercially available reagents. Clin Chem. 20:369-375.
17. Kleerekoper M, Cruz C, Bernstein RS, Levin NW, Foreback CC, Parfitt AM. 1980 The phosphaturic action of PTH in the steady state in patients with normal and impaired renal function. In: Massry S, Ritz E, John H, eds. Phosphate and minerals in health and disease. Advances in experimental and biological medicine. New York: Plenum Press; vol 128:145-154.
18. Bijvoet OLM, Sluys Veer JVD. 1972 The interpretation of laboratory tests on bone disease. Clin Endocrinol Metab. 1:217-237.
19. Parfitt AM, Kleerekoper M, Cruz C. 1986 Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidism in chronic renal failure. Miner Electrolyte Metab. 12:356-362.
20. Wilson PS, Kleerekoper M, Bone H, Parfitt AM. 1990 Measurement of urinary hydroxyproline by HPLC: comparison of spot and timed urine collections. Clin Chem. 36:388-389.
21. Parfitt AM, Podenphant J, Villanueva AR, Frame B. 1985 Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: a bone histomorphometric study. Bone. 6:211-220.
22. Foldes J, Parfitt AM, Shih M-S, Rao DS, Kleerekoper M. 1991 Structural and geometric changes in iliac bone: relationship to normal aging and osteoporosis. J Bone Miner Res. 6:759-766.
23. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS. 1983 Relationship between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis: implications for the microanatomic and cellular mechanism of bone loss. J Clin Invest. 72:1396-1409.
24. DeHaas WHD, DeBoer W, Griffioen F. 1969 Metaphysial dysostosis. J Bone Joint Surg. 51B:290-299.
25. Kleerekoper M. 1994 Clinical course of primary hyperparathyroidism. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids-basic and clinical concepts. New York: Raven Press; 471-483.
26. Parfitt AM. 1990 Interpretation of bone densitometry measurements: the disadvantages of a percentage scale and a discussion of available alternatives. J Bone Miner Res. 5:537-540.
27. Parfitt AM. 1964 Hypercalcemic nephropathy. Med J Aust. 2:127-134.
28. Robbins LS, Nadeau JH, Johnson KR, et al. 1993 Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell. 72:827-834.
29. Lefkowitz RJ. 1993 Turned on to ill effect. Nature. 365:603-604.
30. Parfitt AM. 1993 Calcium homeostasis. In: Mundy GR, Martin TJ, eds. Handbook of experimental pharmacology. Physiology and pharmacology of bone. Heidelberg: Springer-Verlag; vol 107:1-65.
31. Bronner F, Stein WD. 1992 Modulation of bone calcium-binding sites regulates plasma calcium-an hypothesis. Calcif Tissue Int. 50:483-489.
32. Bronner F, Stein WD. 1995 Calcium homeostasis-an old problem revisited. J Nutr. 125:S1987-S1995.
33. Segre GV. 1994 Receptors for parathyroid hormone and parathyroid hormone-related protein. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids-basic and clinical concepts. New York: Raven Press; 213-229.
34. Parfitt AM. 1994 Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem. 55:273-286.
35. Parfitt AM, Mundy GR, Roodman GD, Hughes DE, Boyce B. 1996 A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates. J Bone Miner Res. 11:150-159.
36. Heersche JNM, Bellows CG, Aubin JE. 1994 Cellular actions of parathyroid hormone on osteoblast and osteoclast differentiation. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids-basic and clinical concepts. New York: Raven Press; 83-91.
37. Parisien M, Dempster DW, Shane E, Bilezikian JP. 1994 Histomorphometric analysis of bone in primary hyperparathyroidism. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids-basic and clinical concepts. New York: Raven Press; 493-503.
38. Coleman DT, Fitzpatrick LA, Bilezikian JP. 1994 Biochemical mechanisms of parathyroid hormone action, In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids-basic and clinical concepts. New York: Raven Press; 239-258.
39. Murray TM, Rao LG, Rizzoli RE. 1994 Interactions of parathyroid hormone, parathyroid hormone-related protein, and their fragments with conventional and nonconventional receptor sites. 17:190-198. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids-basic and clinical concepts. New York: Raven Press; 185-211.
40. Mallette LE. 1994 Parathyroid hormone and parathyroid hormone-related protein as polyhormones. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids-basic and clinical concepts. New York: Raven Press; 171-184.
41. Parfitt AM. 1976 The actions of parathyroid hormone on bone. Relation to bone remodelling and turnover, calcium homeostasis and metabolic bone disease. III. PTH and osteoblasts, the relationship between bone turnover and bone loss, and the state of the bones in primary hyperparathyroidism. Metabolism. 25: 1033-1069.